शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
PLATINDBSEPLATINUM INDUSTRIES LTD· Chemicals & PetrochemicalsHighNeutral
Announced Wed, 4 Nov, 2026 · 18:58 IST

Quarter ended Sept 2026: consolidated revenue up 23%, profit after tax down 31% vs Sept 2025

Revenue growth above 20%EBITDA margin compressionQualified audit opinionResults View source PDFExplain this filing

PLATIND · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-1.9%Reaction day
₹217.93
prior close
₹218.03
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is usedpendingvs market: pending
Specialty Chemicals peers, median of 100sector+0.7%-2.5% vs sector

On the reaction day the stock moved 2.5 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-3.2
10m
-3.4
15m
-3.7
30m
-3.7
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-1.9pendingpending+0.7-2.5
Next day
-2.7pendingpending+0.0-2.7
2d
—————
3d
—————
4d
—————
5d
—————
1w
—————
15d
—————
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Specialty Chemicals peers, median of 100Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Consolidated quarter ended 30 September 2026: revenue rose 23.3% to Rs 1,212.66 million from Rs 983.78 million in the year-ago quarter, while profit after tax fell 30.8% to Rs 75.98 million from Rs 109.83 million. Operating margin before interest, tax, depreciation and amortisation narrowed from 13.8% to 8.9%. The auditor qualified both reviews over an unconfirmed Rs 98.19 million insurance claim.

Likely market impact

Revenue growth helps, but profit and margins weakened, which may pressure the stock. The qualified review adds uncertainty over the insurance claim.

By the numbersConsolidated · Q2 FY27 vs Q2 FY26
Q2 FY27Q2 FY26Change
Revenue₹121.3 Cr₹98.38 Cr+23.3%
Operating profit₹7.74 Cr₹11.21 Cr−30.9%
Profit after tax₹7.60 Cr₹10.98 Cr−30.8%
EBITDA margin8.9%13.3%−4.3 pp

From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.